Literature DB >> 34089424

FRAX-based intervention thresholds in eight Eurasian countries: Armenia, Belarus, Georgia, Kazakhstan, the Kyrgyz Republic, Moldova, the Russian Federation, and Uzbekistan.

Olga Lesnyak1, Alla Zakroyeva2, Varta Babalyan3, Victor Cazac4, Gulzhan Gabdulina5, Said Ismailov6, Olga Lobanchenko7, Ema Rudenka8, Marina Tsagareli9, Helena Johansson10, Nickolas C Harvey11, Eugene McCloskey12, John A Kanis10,12.   

Abstract

Age-specific intervention and assessment thresholds based on FRAX® were developed for eight Eurasian countries participating in the EVA study (Armenia, Belarus, Georgia, Moldova, Kazakhstan, the Kyrgyz Republic, the Russian Federation, and Uzbekistan). The intervention thresholds (major osteoporotic fracture) ranged from 3.6 (Armenia and Georgia) to 12.3% (Uzbekistan) for people at age 50 years, and from 16 (Armenia) to 27% (Belarus) at the age of 90 years. These thresholds enable a substantial advance in the ease of detection of individuals at high fracture risk.
INTRODUCTION: The purpose of this study was to derive and compare FRAX-based intervention and BMD assessment thresholds for 8 Eurasian countries in the EVA study.
METHODS: The intervention threshold (IT) was set at a 10-year probability of a major osteoporotic fracture (MOF), calculated without BMD, equivalent to a woman with a prior fragility fracture but no other clinical risk factors, and a body mass index (BMI) of 25.0 kg/m2. The lower assessment threshold was set at a 10-year probability of a MOF in women with BMI of 25.0 kg/m2, without previous fracture or other clinical risk factors. The upper assessment threshold was set at 1.2 times the IT.
RESULTS: The age-specific intervention thresholds ranged from 3.6 (Armenia and Georgia) to 12.3% (Uzbekistan) for men and women at the age of 50 years and from 16 (Armenia) to 27% (Belarus) at the age of 90 years. The difference between countries was most evident at younger ages and become progressively less with advancing age.
CONCLUSIONS: For the 8 Eurasian countries, the newly established FRAX-based intervention thresholds provide an opportunity to improve the clinical detection of both men and women with a high risk of fracture and improve treatment rates.

Entities:  

Keywords:  Assessment threshold; Epidemiology; FRAX; Fracture probability; Intervention threshold; Major osteoporotic fracture; Osteoporosis

Mesh:

Year:  2021        PMID: 34089424     DOI: 10.1007/s11657-021-00962-1

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  16 in total

Review 1.  Treatment of established osteoporosis: a systematic review and cost-utility analysis.

Authors:  J A Kanis; J E Brazier; M Stevenson; N W Calvert; M Lloyd Jones
Journal:  Health Technol Assess       Date:  2002       Impact factor: 4.014

2.  Epidemiology of fracture in the Russian Federation and the development of a FRAX model.

Authors:  Olga Lesnyak; Olga Ershova; Ksenia Belova; Elena Gladkova; Olga Sinitsina; Olga Ganert; Marina Romanova; Vitalij Khodirev; Helena Johansson; Eugene McCloskey; John A Kanis
Journal:  Arch Osteoporos       Date:  2012-05-09       Impact factor: 2.617

3.  Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden.

Authors:  John A Kanis; Olof Johnell; Anders Oden; Frederik Borgstrom; Helena Johansson; Chris De Laet; Bengt Jönsson
Journal:  Osteoporos Int       Date:  2004-04-22       Impact factor: 4.507

4.  Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK.

Authors:  J Compston; A Cooper; C Cooper; R Francis; J A Kanis; D Marsh; E V McCloskey; D M Reid; P Selby; M Wilkins
Journal:  Maturitas       Date:  2009-01-08       Impact factor: 4.342

5.  Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models.

Authors:  H Ramanau; I Chernyanin; E Rudenka; O Lesnyak; A Zakroyeva; J P Bilezikian; H Johansson; N C Harvey; E V McCloskey; J A Kanis
Journal:  Arch Osteoporos       Date:  2018-04-17       Impact factor: 2.617

6.  Epidemiology of hip fracture and the development of a FRAX model for Uzbekistan.

Authors:  O Lesnyak; S Ismailov; M Shakirova; N Alikhanova; A Zakroyeva; L Abboskhujaeva; H Johansson; N C Harvey; E McCloskey; J A Kanis
Journal:  Arch Osteoporos       Date:  2020-07-29       Impact factor: 2.617

7.  Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model.

Authors:  S Issayeva; O Lesnyak; A Zakroyeva; B Issayeva; D Dilmanova; H Johansson; E Liu; M Lorentzon; N C Harvey; E McCloskey; J A Kanis
Journal:  Arch Osteoporos       Date:  2020-02-27       Impact factor: 2.617

8.  Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model.

Authors:  Alla Zakroyeva; Olga Lesnyak; Victor Cazac; Liliana Groppa; Eugen Russu; Lia Chislari; Larisa Rotaru; Helena Johansson; Nicholas C Harvey; Eugene McCloskey; Mattis Lorentzon; John A Kanis
Journal:  Arch Osteoporos       Date:  2020-01-28       Impact factor: 2.617

9.  SCOPE: a scorecard for osteoporosis in Europe.

Authors:  J A Kanis; F Borgström; J Compston; K Dreinhöfer; E Nolte; L Jonsson; W F Lems; E V McCloskey; R Rizzoli; J Stenmark
Journal:  Arch Osteoporos       Date:  2013-09-13       Impact factor: 2.617

10.  Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate.

Authors:  O Lesnyak; S Sahakyan; A Zakroyeva; J P Bilezikian; N Hutchings; V Babalyan; R Galstyan; A Lebedev; H Johansson; N C Harvey; E McCloskey; John A Kanis
Journal:  Arch Osteoporos       Date:  2017-11-07       Impact factor: 2.617

View more
  2 in total

1.  FRAX-based intervention thresholds for Pakistan.

Authors:  H Johansson; G Naureen; R Iqbal; L Jafri; A H Khan; M Umer; E Liu; L Vandenput; M Lorentzon; E V McCloskey; J A Kanis; N C Harvey
Journal:  Osteoporos Int       Date:  2021-08-20       Impact factor: 4.507

2.  Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group.

Authors:  P Chotiyarnwong; E V McCloskey; N C Harvey; M Lorentzon; D Prieto-Alhambra; B Abrahamsen; J D Adachi; F Borgström; O Bruyere; J J Carey; P Clark; C Cooper; E M Curtis; E Dennison; M Diaz-Curiel; H P Dimai; D Grigorie; M Hiligsmann; P Khashayar; E M Lewiecki; P Lips; R S Lorenc; S Ortolani; A Papaioannou; S Silverman; M Sosa; P Szulc; K A Ward; N Yoshimura; J A Kanis
Journal:  Arch Osteoporos       Date:  2022-06-28       Impact factor: 2.879

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.